| 1 |
Yu X, Shao K, Wan K, Li T, Li Y, Zhu X, Han Y. Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease. Chin Med J (Engl) 2023. [PMID: 36914945 DOI: 10.1097/CM9.0000000000002566] [Reference Citation Analysis]
|
| 2 |
Wang G, Shen X, Song X, Wang N, Wo X, Gao Y. Protective mechanism of gold nanoparticles on human neural stem cells injured by β-amyloid protein through miR-21-5p/SOCS6 pathway. Neurotoxicology 2023;95:12-22. [PMID: 36623431 DOI: 10.1016/j.neuro.2022.12.011] [Reference Citation Analysis]
|
| 3 |
Li K, Chi R, Liu L, Feng M, Su K, Li X, He G, Shi Y. 3D genome-selected microRNAs to improve Alzheimer's disease prediction. Front Neurol 2023;14:1059492. [PMID: 36860572 DOI: 10.3389/fneur.2023.1059492] [Reference Citation Analysis]
|
| 4 |
Lukiw WJ, Pogue AI. Endogenous miRNA-Based Innate-Immunity against SARS-CoV-2 Invasion of the Brain. Int J Mol Sci 2023;24. [PMID: 36834773 DOI: 10.3390/ijms24043363] [Reference Citation Analysis]
|
| 5 |
Boccardi V, Poli G, Cecchetti R, Bastiani P, Scamosci M, Febo M, Mazzon E, Bruscoli S, Brancorsini S, Mecocci P. miRNAs and Alzheimer's Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population. Nutrients 2023;15. [PMID: 36771341 DOI: 10.3390/nu15030634] [Reference Citation Analysis]
|
| 6 |
Zhou Y, Wang X, Liu Y, Gu Y, Gu R, Zhang G, Lin Q. Mechanisms of abnormal adult hippocampal neurogenesis in Alzheimer's disease. Front Neurosci 2023;17:1125376. [PMID: 36875663 DOI: 10.3389/fnins.2023.1125376] [Reference Citation Analysis]
|
| 7 |
Zhang S, Meng Y, Zhou L, Qiu L, Wang H, Su D, Zhang B, Chan K, Han J. Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. MedComm 2022;3. [DOI: 10.1002/mco2.173] [Reference Citation Analysis]
|
| 8 |
Song J, Wang J, Liu K, Xu W, Sun T, Liu J. The role of microRNAs in erectile dysfunction: From pathogenesis to therapeutic potential. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1034043] [Reference Citation Analysis]
|
| 9 |
Zhao Y, Jaber VR, Lukiw WJ. SARS-CoV-2, long COVID, prion disease and neurodegeneration. Front Neurosci 2022;16:1002770. [DOI: 10.3389/fnins.2022.1002770] [Reference Citation Analysis]
|
| 10 |
Lukiw WJ, Jaber VR, Pogue AI, Zhao Y. SARS-CoV-2 Invasion and Pathological Links to Prion Disease. Biomolecules 2022;12. [PMID: 36139092 DOI: 10.3390/biom12091253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Zhao Y, Jaber VR, Lukiw WJ. Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD. Front Drug Discov 2022;2. [DOI: 10.3389/fddsv.2022.983030] [Reference Citation Analysis]
|
| 12 |
Nikolenko VN, Rizaeva NA, Bulygin KV, Anokhina VM, Bolotskaya AA. The role of oxidative stress in the development of Alzheimer's disease. RJTAO 2022;14:68-74. [DOI: 10.14412/2074-2711-2022-4-68-74] [Reference Citation Analysis]
|
| 13 |
Jia L, Zhu M, Yang J, Pang Y, Wang Q, Li T, Li F, Wang Q, Li Y, Wei Y. Exosomal MicroRNA-Based Predictive Model for Preclinical Alzheimer's Disease: A Multicenter Study. Biol Psychiatry 2022;92:44-53. [PMID: 35221095 DOI: 10.1016/j.biopsych.2021.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 14 |
Bonk S, Kirchner K, Ameling S, Garvert L, Völzke H, Nauck M, Völker U, Grabe HJ, Van der Auwera S. APOE ε4 in Depression-Associated Memory Impairment—Evidence from Genetic and MicroRNA Analyses. Biomedicines 2022;10:1560. [DOI: 10.3390/biomedicines10071560] [Reference Citation Analysis]
|
| 15 |
Pogue AI, Jaber VR, Sharfman NM, Zhao Y, Lukiw WJ. Downregulation of Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p. Front Neurol 2022;13:900048. [DOI: 10.3389/fneur.2022.900048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Romanescu C, Schreiner TG, Mukovozov I. The Role of Human Herpesvirus 6 Infection in Alzheimer’s Disease Pathogenicity—A Theoretical Mosaic. JCM 2022;11:3061. [DOI: 10.3390/jcm11113061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Ramaswamy P, Christopher R, Kumar Pal P, Debnath M, Yadav R. Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy. Diagnostics 2022;12:1204. [DOI: 10.3390/diagnostics12051204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Lukiw WJ. Fission Impossible: Stabilized miRNA-Based Analogs in Neurodegenerative Disease. Front Neurosci 2022;16:875957. [DOI: 10.3389/fnins.2022.875957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Nguyen TPN, Kumar M, Fedele E, Bonanno G, Bonifacino T. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Int J Mol Sci 2022;23:4718. [PMID: 35563107 DOI: 10.3390/ijms23094718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 20 |
Mankhong S, Kim S, Lee S, Kwak H, Park D, Joa K, Kang J. Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers. Biomedicines 2022;10:850. [DOI: 10.3390/biomedicines10040850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 21 |
Reddy JS, Jin J, Lincoln SJ, Ho CC, Crook JE, Wang X, Malphrus KG, Nguyen T, Tamvaka N, Greig-custo MT, Lucas JA, Graff-radford NR, Ertekin-taner N, Carrasquillo MM. Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans. eBioMedicine 2022;78:103929. [DOI: 10.1016/j.ebiom.2022.103929] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 22 |
Soelter TM, Whitlock JH, Williams AS, Hardigan AA, Lasseigne BN. Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities. Heliyon 2022;8:e09239. [PMID: 35469332 DOI: 10.1016/j.heliyon.2022.e09239] [Reference Citation Analysis]
|
| 23 |
Zheng Y, Xu Q, Jin Q, Du Y, Yan J, Gao H, Zheng H. Urinary and faecal metabolic characteristics in APP/PS1 transgenic mouse model of Alzheimer's disease with and without cognitive decline. Biochem Biophys Res Commun 2022;604:130-6. [PMID: 35303679 DOI: 10.1016/j.bbrc.2022.03.048] [Reference Citation Analysis]
|
| 24 |
Li G, Liang R, Lian Y, Zhou Y. Circ_0002945 functions as a competing endogenous RNA to promote Aβ25-35-induced endoplasmic reticulum stress and apoptosis in SK-N-SH cells and human primary neurons. Brain Research 2022. [DOI: 10.1016/j.brainres.2022.147878] [Reference Citation Analysis]
|
| 25 |
Li Y, Han X, Fan H, Sun J, Ni M, Zhang L, Fang F, Zhang W, Ma P. Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer’s disease. Neuroscience Letters 2022. [DOI: 10.1016/j.neulet.2022.136531] [Reference Citation Analysis]
|
| 26 |
Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Soloveva K, Volkova M, Alekseeva P, Andryshchenko A, Kostyuk G, Gurina O, Chekhonin V. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. Int J Mol Sci 2022;23:1217. [PMID: 35163141 DOI: 10.3390/ijms23031217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 27 |
Sun Y, Li F, Liu X, Qin T, Li T, Zheng H, Alwarappan S, Ostrikov K(. Inter-lamellar nanostructures-by-design for high-performance dual-photoelectrode photofuel cell based genosensor. Sensors and Actuators B: Chemical 2022;350:130838. [DOI: 10.1016/j.snb.2021.130838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 28 |
Kim S, Cho H. A Review on the Correlation between the Pathology of Alzheimer's Disease and microRNA. Biomed Sci Letters 2021;27:208-215. [DOI: 10.15616/bsl.2021.27.4.208] [Reference Citation Analysis]
|
| 29 |
Zhao Y, Arceneaux L, Culicchia F, Lukiw WJ. Neurofilament Light (NF-L) Chain Protein from a Highly Polymerized Structural Component of the Neuronal Cytoskeleton to a Neurodegenerative Disease Biomarker in the Periphery. HSOA J Alzheimers Neurodegener Dis 2021;7:056. [PMID: 34881359 DOI: 10.24966/AND-9608/100056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 30 |
Turk A, Kunej T, Peterlin B. MicroRNA-Target Interaction Regulatory Network in Alzheimer's Disease. J Pers Med 2021;11:1275. [PMID: 34945753 DOI: 10.3390/jpm11121275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 31 |
Yacovzada NS, Hornstein E. microRNAs trip down memory lane. EMBO Mol Med 2021;13:e14997. [PMID: 34672084 DOI: 10.15252/emmm.202114997] [Reference Citation Analysis]
|
| 32 |
Perdoncin M, Konrad A, Wyner JR, Lohana S, Pillai SS, Pereira DG, Lakhani HV, Sodhi K. A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders. Front Mol Neurosci 2021;14:756499. [PMID: 34690698 DOI: 10.3389/fnmol.2021.756499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 33 |
Campese N, Beatino MF, Del Gamba C, Belli E, Giampietri L, Del Prete E, Galgani A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F. Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer's and other neurodegenerative diseases. Expert Rev Neurother 2021;:1-19. [PMID: 34365867 DOI: 10.1080/14737175.2021.1965879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 34 |
Zhang M, He P, Bian Z. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers. Front Mol Neurosci 2021;14:685143. [PMID: 34421536 DOI: 10.3389/fnmol.2021.685143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 35 |
Dong X, Cong S. MicroRNAs in Huntington's Disease: Diagnostic Biomarkers or Therapeutic Agents? Front Cell Neurosci 2021;15:705348. [PMID: 34421543 DOI: 10.3389/fncel.2021.705348] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 36 |
Suster I, Feng Y. Multifaceted Regulation of MicroRNA Biogenesis: Essential Roles and Functional Integration in Neuronal and Glial Development. Int J Mol Sci 2021;22:6765. [PMID: 34201807 DOI: 10.3390/ijms22136765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 37 |
Mogavero MP, Silvani A, DelRosso LM, Salemi M, Ferri R. Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity. Cancers (Basel) 2021;13:2612. [PMID: 34073579 DOI: 10.3390/cancers13112612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 38 |
Combi R, Salsone M, Villa C, Ferini-Strambi L. Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges. Int J Mol Sci 2021;22:3960. [PMID: 33921279 DOI: 10.3390/ijms22083960] [Reference Citation Analysis]
|
| 39 |
Nagaraj S, Want A, Laskowska-Kaszub K, Fesiuk A, Vaz S, Logarinho E, Wojda U. Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression. Int J Mol Sci 2021;22:3653. [PMID: 33915734 DOI: 10.3390/ijms22073653] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 40 |
Giuliani A, Gaetani S, Sorgentoni G, Agarbati S, Laggetta M, Matacchione G, Gobbi M, Rossi T, Galeazzi R, Piccinini G, Pelliccioni G, Bonfigli AR, Procopio AD, Albertini MC, Sabbatinelli J, Olivieri F, Fazioli F. Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease. Front Aging Neurosci 2021;13:647015. [PMID: 33776746 DOI: 10.3389/fnagi.2021.647015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 41 |
Vergallo A, Lista S, Zhao Y, Lemercier P, Teipel SJ, Potier MC, Habert MO, Dubois B, Lukiw WJ, Hampel H; INSIGHT-preAD study group, Alzheimer Precision Medicine Initiative (APMI). MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints. Transl Psychiatry 2021;11:78. [PMID: 33504764 DOI: 10.1038/s41398-020-01184-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 42 |
Siedlecki-Wullich D, Miñano-Molina AJ, Rodríguez-Álvarez J. microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective. Cells 2021;10:113. [PMID: 33435363 DOI: 10.3390/cells10010113] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 43 |
Zhao Y, Jaber V, Lukiw WJ. Gastrointestinal Tract Microbiome-Derived Pro-inflammatory Neurotoxins in Alzheimer's Disease. J Aging Sci 2021;9:002. [PMID: 34671696] [Reference Citation Analysis]
|
| 44 |
Lukiw WJ, Arceneaux L, Li W, Bond T, Zhao Y. Gastrointestinal (GI)-Tract Microbiome Derived Neurotoxins and their Potential Contribution to Inflammatory Neurodegeneration in Alzheimer's Disease (AD). J Alzheimers Dis Parkinsonism 2021;11:525. [PMID: 34457996] [Reference Citation Analysis]
|
